For the treatment of asthma in children, the recommended dose of prednisolone is 1-2 mg/kg once daily for a period of 3-5 days.

The management of acute asthma attacks in children depends on the severity of the attack. Children with severe or life-threatening asthma should be immediately transferred to the hospital. For children with mild to moderate acute asthma, bronchodilator therapy and steroid therapy should be given. The dosage of prednisolone depends on the age of the child. It is important to monitor SpO2, PEF, heart rate, respiratory rate, use of accessory neck muscles, and other clinical features to determine the severity of the attack.

Converting Oral Morphine to Subcutaneous Infusion

In order to convert oral morphine to a 24 hour subcutaneous infusion of morphine, the total 24 hour oral dose must be calculated. For example, if the patient is taking a 12 hour release preparation of 60mg, the total daily dose of oral morphine is 120mg. To convert this to a 24 hour subcutaneous infusion of morphine, the figure must be divided by two. For diamorphine, the figure would be divided by three. Therefore, the patient needs 60mg morphine over 24 hours.

It is important to note that the question asks for the volume of morphine over 24 hours, not the dose. If the ampoules are 10 mg/ml, then to deliver 60mg in 24 hours, 6 x 10 mg/ml = 6 ml is needed. It is crucial to read the question carefully to ensure the correct answer is given.

Factors Associated with Macular Edema in Diabetes

In diabetes, macular edema is a common cause of visual loss and can result from various factors such as macular capillary non-perfusion, vitreous hemorrhage, and distortion or traction detachment of the retina. The severity of diabetic retinopathy, male gender, higher glycosylated hemoglobin, proteinuria, higher systolic and diastolic blood pressure, and smoking history are all associated with a higher incidence of macular edema, according to The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Contrary to popular belief, low glycosylated hemoglobin is not associated with macular edema. However, hypercholesterolemia and other cardiovascular risk factors can influence the onset and progression of retinopathy and should be monitored. While peripheral vascular disease is a risk factor for diabetes, it is not directly associated with macular edema. Overall, understanding the factors associated with macular edema in diabetes can help healthcare professionals identify and manage patients at risk for this complication.

The ANA test is commonly used to screen for autoimmune rheumatic diseases in adults, but it is not very accurate without typical clinical features. While tests like anti-dsDNA are more specific for SLE, they are less sensitive, meaning a negative result doesn’t necessarily rule out the condition.

Systemic lupus erythematosus (SLE) can be investigated through various tests, including antibody tests. ANA testing is highly sensitive and useful for ruling out SLE, but it has low specificity. About 99% of SLE patients are ANA positive. Rheumatoid factor testing is positive in 20% of SLE patients. Anti-dsDNA testing is highly specific (>99%) but less sensitive (70%). Anti-Smith testing is also highly specific (>99%) but has a lower sensitivity (30%). Other antibody tests that can be used include anti-U1 RNP, SS-A (anti-Ro), and SS-B (anti-La).

Monitoring of SLE can be done through various markers, including inflammatory markers such as ESR. During active disease, CRP levels may be normal, and a raised CRP may indicate an underlying infection. Complement levels (C3, C4) are low during active disease due to the formation of complexes that lead to the consumption of complement. Anti-dsDNA titres can also be used for disease monitoring, but it is important to note that they are not present in all SLE patients. Overall, these investigations can help diagnose and monitor SLE, allowing for appropriate management and treatment.

The patient exhibits symptoms of congestive heart failure, which can be managed with loop diuretics and nitrates in acute or decompensated cases. However, these medications do not improve long-term survival. To reduce mortality in patients with left ventricular failure, ACE-inhibitors, beta-blockers, angiotensin receptor blockers, aldosterone antagonists, and hydralazine with nitrates have all been proven effective. Digoxin can reduce hospital admissions but not mortality, and is typically used in patients with worsening heart failure despite initial treatments or those with co-existing atrial fibrillation.

Chronic heart failure can be managed through drug therapy, as outlined in the updated guidelines issued by NICE in 2018. While loop diuretics are useful in managing fluid overload, they do not reduce mortality in the long term. The first-line treatment for all patients is an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Aldosterone antagonists are the standard second-line treatment, but both ACE inhibitors and aldosterone antagonists can cause hyperkalaemia, so potassium levels should be monitored. SGLT-2 inhibitors are increasingly being used to manage heart failure with a reduced ejection fraction, as they reduce glucose reabsorption and increase urinary glucose excretion. Third-line treatment options include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, and cardiac resynchronisation therapy. Other treatments include annual influenza and one-off pneumococcal vaccines.

Correcting Misconceptions About Child Health: Understanding When to Seek Medical Advice

As a parent or caregiver, it can be difficult to know when to seek medical advice for a child’s health concerns. However, it is important to correct some common misconceptions to ensure that children receive appropriate care.

Firstly, if a parent or caregiver feels that a child has become less well, they should seek further advice. Additionally, if they are distressed or concerned about their ability to care for the child, seeking advice is recommended.

Contrary to popular belief, a strong normal cry is not a cause for concern. However, a weak, high-pitched, or continuous cry is a red flag. Similarly, a non-blanching rash should cause concern, as it may indicate meningococcal septicaemia.

Parents should seek further advice if a fever is still present after five days, not two. A temperature rise up to 39°C in the absence of other worrying signs is not a reason for concern in a child of this age. However, if a child has a febrile fit, parents should seek immediate advice.

By understanding these misconceptions and knowing when to seek medical advice, parents and caregivers can ensure that children receive appropriate care for their health concerns.

Common Oral Conditions and Their Symptoms

Geographic tongue is a common oral condition that presents with mild burning and irritation of the tongue. It is characterized by single or multiple well-demarcated irregular but smooth red plaques on the dorsum of the tongue. Stress and spicy food may exacerbate the condition.

Angular chelitis, on the other hand, presents with irritation of the corners of the lips and dryness. Aphthous stomatitis describes solitary or multiple painful ulcers on the mucosal membranes. Oral hairy leukoplakia is an asymptomatic white thickening and accentuation of the folds of the lateral margins of the tongue.

Lastly, acute necrotising ulcerative gingivitis presents with punched-out ulcers, necrosis, and bleeding of areas between teeth. It is important to be aware of these common oral conditions and their symptoms to seek appropriate management and treatment.

Nasal Polyps: Causes, Symptoms, and Treatment

Nasal polyps are growths that develop in the nasal passages, with the majority arising in the ethmoid sinuses. While allergy is the main cause, there may also be an infective component. Antrochoanal polyps, which are associated with chronic infection, are much rarer and arise from the maxillary sinuses. These growths have a yellowish-grey appearance, and any pink or red polyps should be regarded as suspicious.

Symptoms of nasal polyps include blockage of the nasal passages, leading to anosmia or loss of smell. Treatment typically involves the use of topical steroids, which can help to reduce the size of the polyps. However, surgical removal may be necessary in some cases, and recurrence is common. While smell is usually restored after treatment, it may not always be fully regained. Overall, understanding the causes, symptoms, and treatment options for nasal polyps can help individuals to manage this condition effectively.

Patients should be cautioned that vaginal and topical imidazoles, such as clotrimazole, may harm barrier methods of contraception. However, there is no clear guidance on the duration of abstinence or use of non-barrier methods. According to NICE CKS, patients should avoid using barrier methods during treatment and for several days after stopping antifungal treatment.

Limited evidence suggests that the combined oral contraceptive pill may contribute to the development of genital Candida infection. Patients with recurrent infections may benefit from switching to the progesterone depot injection. While the IUS increases the presence of Candida, it doesn’t increase the rate of symptomatic infection.

Vaginal candidiasis, commonly known as ‘thrush’, is a prevalent condition that many women self-diagnose and treat. Candida albicans is responsible for 80% of cases, while other candida species cause the remaining 20%. Although most women have no predisposing factors, certain conditions such as diabetes mellitus, drug use (antibiotics, steroids), pregnancy, and immunosuppression (HIV) may increase the likelihood of developing vaginal candidiasis. Symptoms include non-offensive discharge resembling cottage cheese, vulvitis, dyspareunia, dysuria, itching, vulval erythema, fissuring, and satellite lesions.

Routine high vaginal swabs are not necessary if the clinical features are consistent with candidiasis. Treatment options include local or oral therapy. The NICE Clinical Knowledge Summaries recommends oral fluconazole 150 mg as a single dose as the first-line treatment. If oral therapy is contraindicated, a single dose of clotrimazole 500 mg intravaginal pessary may be used. If vulval symptoms are present, a topical imidazole may be added to an oral or intravaginal antifungal. Pregnant women should only use local treatments such as cream or pessaries, as oral treatments are not recommended.

Recurrent vaginal candidiasis is defined as four or more episodes per year by BASHH. Compliance with previous treatment should be checked, and the diagnosis of candidiasis should be confirmed. A high vaginal swab for microscopy and culture may be necessary, and a blood glucose test should be performed to exclude diabetes. Differential diagnoses such as lichen sclerosus should also be ruled out. An induction-maintenance regime may be used, consisting of oral fluconazole every three days for three doses as induction, followed by oral fluconazole weekly for six months as maintenance.

As per the current NICE CKS guidance, individuals who are above 50 years of age and have a previous fragility fracture should be referred for a DEXA scan to measure bone mineral density (BMD). It is not necessary to calculate their QFracture risk or FRAX score before arranging the scan. Even if their QFracture risk is low, they are still at risk due to their history of fragility fracture. For patients over 75 years of age who have had a fragility fracture, treatment (oral bisphosphonates as first line) should be initiated immediately without the need for a DEXA scan. However, it is important to note that this differs from the NOGG guidelines 2014, which recommend treatment for all women over 50 years who have had a fragility fracture.

Osteoporosis is a condition that weakens bones, making them more prone to fractures. When a patient experiences a fragility fracture, which is a fracture that occurs from a low-impact injury or fall, it is important to assess their risk for osteoporosis and subsequent fractures. The management of patients following a fragility fracture depends on their age.

For patients who are 75 years of age or older, they are presumed to have underlying osteoporosis and should be started on first-line therapy, such as an oral bisphosphonate, without the need for a DEXA scan. However, the 2014 NOGG guidelines suggest that treatment should be started in all women over the age of 50 years who’ve had a fragility fracture, although BMD measurement may sometimes be appropriate, particularly in younger postmenopausal women.

For patients who are under the age of 75 years, a DEXA scan should be arranged to assess their bone mineral density. These results can then be entered into a FRAX assessment, along with the fact that they’ve had a fracture, to determine their ongoing fracture risk. Based on this assessment, appropriate treatment can be initiated to prevent future fractures.